PC-PLD1A Inhibitors
PC-PLD1A inhibitors are a specialized group of chemical compounds that specifically inhibit the activity of phosphatidylcholine-specific phospholipase D1A (PLD1A), an enzyme integral to lipid signaling pathways. PLD1A catalyzes the hydrolysis of phosphatidylcholine to produce phosphatidic acid and choline, a reaction that plays a pivotal role in membrane dynamics and intracellular signaling. This enzyme is involved in various cellular processes, including vesicle trafficking, cytoskeletal organization, and regulation of cell proliferation. By inhibiting PLD1A, researchers can modulate these processes to study the enzyme's specific functions and its impact on cellular physiology.
The design and synthesis of PC-PLD1A inhibitors involve identifying compounds that can effectively bind to the active site of PLD1A or interfere with its regulatory interactions. These inhibitors may consist of diverse chemical entities such as small organic molecules, nucleotide analogs, or peptides that exhibit high specificity toward PLD1A. Advanced techniques like structure-based drug design, molecular docking simulations, and high-throughput screening are employed to discover and optimize these inhibitors. By utilizing PC-PLD1A inhibitors in experimental settings, scientists can unravel the complexities of lipid-mediated signaling pathways, explore the mechanisms of membrane-associated processes, and gain insights into how PLD1A influences cellular responses to environmental cues. This research enhances the fundamental understanding of enzyme regulation and the intricate networks that govern cell function and communication.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Suberoylanilide Hydroxamic Acid, as a histone deacetylase inhibitor, could downregulate PC-PLD1A expression by promoting the acetylation of histones, leading to a closed chromatin conformation less conducive to transcriptional activation. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
By inhibiting DNA methyltransferases, 5-Azacytidine may cause demethylation of gene promoter regions, potentially reducing the expression of PC-PLD1A if its promoter is typically silenced by methylation. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A could decrease PC-PLD1A expression through the inhibition of histone deacetylases, which may result in hyperacetylation and subsequent transcriptional repression of the gene encoding this protein. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid might repress PC-PLD1A expression by binding to retinoic acid receptors that interact with promoter regions of target genes, altering the transcription machinery's access to the PC-PLD1A gene. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits the mTOR pathway, which could lead to a broad reduction in cap-dependent mRNA translation, possibly including mRNAs that code for PC-PLD1A, thereby decreasing its protein levels. | ||||||
Spironolactone | 52-01-7 | sc-204294 | 50 mg | $109.00 | 3 | |
As an antagonist of aldosterone, Spironolactone could inhibit PC-PLD1A gene expression in aldosterone-responsive tissues by preventing the activation of aldosterone-regulated transcription factors. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
By binding to GC-rich sequences in DNA, Mithramycin A might inhibit the binding of transcription factors to the PC-PLD1A promoter, leading to a decrease in the initiation of its transcription. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD 98059 may decrease PC-PLD1A expression by inhibiting MEK, which is upstream of ERK; this could disrupt the phosphorylation and activation of transcription factors that drive PC-PLD1A gene transcription. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY 294002, by inhibiting PI3K, could lead to a decrease in Akt signaling, potentially reducing transcriptional activation of PC-PLD1A by affecting transcription factors that are regulated by the PI3K/Akt pathway. | ||||||
2-Methoxyestradiol | 362-07-2 | sc-201371 sc-201371A | 10 mg 50 mg | $71.00 $288.00 | 6 | |
2-Methoxyestradiol might reduce PC-PLD1A expression by binding to estrogen receptors, leading to altered gene transcription patterns that repress the PC-PLD1A gene. | ||||||